Clinical Trial Update: Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating induction/simplification with boosted atazanavir/ritonavir plus abacavir/lamivudine fixed-dose combination in HIV-1 infection. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• Norvir (ritonavir)
• REYATAZ (atazanavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 3 | Status: COMPLETED | Results posted: 2011-08-17